MeSH Browser

MeSH Heading: Lincomycin
Tree Number(s): D03.383.773.532.500; D09.408.471.500
Unique ID: D008034
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D008034
Scope Note: An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
Entry Term(s): Epilincomycin; Lincocin; Lincolnensin; Lincomycin A; Lincomycin Hydrochloride; Lincomycin Monohydrochloride; Lincomycin Monohydrochloride, (2S-cis)-Isomer; Lincomycin Monohydrochloride, (L-threo)-Isomer; Lincomycin Monohydrochloride, Hemihydrate; Lincomycin, (2S-cis)-Isomer; Lincomycin, (L-threo)-Isomer
Pharm Action: Anti-Bacterial Agents
Protein Synthesis Inhibitors
Registry Numbers: BOD072YW0F; 0; 17233-07-7; 26389-84-4; M6T05Z2B68; 35410-84-5; 7179-49-9; 859-18-7; 17017-22-0
Related Numbers: 154-21-2; 17017-22-0; 17233-07-7; 26389-84-4; 32124-14-4; 35410-84-5; 7179-49-9; 859-18-7; M6T05Z2B68
CAS Type 1 Name: D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-
NLM Classification #: QV 350
Public MeSH Note: 66
History Note: 66(64)
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/31

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0012521
Registry Numbers: BOD072YW0F
Related Numbers: 154-21-2; 17017-22-0; 17233-07-7; 26389-84-4; 32124-14-4; 35410-84-5; 7179-49-9; 859-18-7; M6T05Z2B68
Scope Note: An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
Terms: Lincomycin Preferred Term
Term UI T023951
Date01/01/1999
LexicalTag NON
ThesaurusID; Lincolnensin
Term UI T023950
Date12/30/1976
LexicalTag NON
ThesaurusID; Lincomycin A
Term UI T023953
Date11/10/1986
LexicalTag NON
ThesaurusID UNK (19XX)

Lincomycin MeSH Descriptor Data 2024